Celebrex adjuvant therapy on COVID-19: An experimental study
Wenxin Hong, Yan Chen, Kai You, Shenglin Tan, Feima Wu, Jiawang Tao, Xudan Chen, Jiaye Zhang, Yue Xiong, Fang Yuan, Zhen Yang, Tingting Chen, Xinwen Chen, Ping Peng, Qiang Tai, Jian Wang, Fuchun Zhang, Yinxiong Li
doi: https://doi.org/10.1101/2020.05.05.20077610
Wenxin Hong
5The Eighth People’s Hospital of Guangzhou, Guangzhou 510060, China;
Yan Chen
1Institute of Public Health, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China;
2Guangdong Provincial Key Laboratory of Biocomputing, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China;
Kai You
1Institute of Public Health, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China;
2Guangdong Provincial Key Laboratory of Biocomputing, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China;
Shenglin Tan
1Institute of Public Health, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China;
4University of Chinese Academy of Sciences, Beijing 100049, China;
Feima Wu
6The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou 510260, China;
Jiawang Tao
1Institute of Public Health, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China;
4University of Chinese Academy of Sciences, Beijing 100049, China;
Xudan Chen
5The Eighth People’s Hospital of Guangzhou, Guangzhou 510060, China;
Jiaye Zhang
1Institute of Public Health, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China;
2Guangdong Provincial Key Laboratory of Biocomputing, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China;
Yue Xiong
1Institute of Public Health, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China;
4University of Chinese Academy of Sciences, Beijing 100049, China;
Fang Yuan
1Institute of Public Health, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China;
4University of Chinese Academy of Sciences, Beijing 100049, China;
Zhen Yang
1Institute of Public Health, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China;
4University of Chinese Academy of Sciences, Beijing 100049, China;
Tingting Chen
1Institute of Public Health, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China;
Xinwen Chen
1Institute of Public Health, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China;
3Guangzhou Regenerative Medicine and Health Guangdong Laboratory, Guangzhou 510700, China;
Ping Peng
5The Eighth People’s Hospital of Guangzhou, Guangzhou 510060, China;
Qiang Tai
7The First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China
Jian Wang
5The Eighth People’s Hospital of Guangzhou, Guangzhou 510060, China;
Fuchun Zhang
5The Eighth People’s Hospital of Guangzhou, Guangzhou 510060, China;
Yinxiong Li
1Institute of Public Health, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China;
2Guangdong Provincial Key Laboratory of Biocomputing, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China;
3Guangzhou Regenerative Medicine and Health Guangdong Laboratory, Guangzhou 510700, China;
4University of Chinese Academy of Sciences, Beijing 100049, China;
Data Availability
The datasets used and/or analyzed during this study are available from the corresponding author on reasonable request.
Posted May 11, 2020.
Celebrex adjuvant therapy on COVID-19: An experimental study
Wenxin Hong, Yan Chen, Kai You, Shenglin Tan, Feima Wu, Jiawang Tao, Xudan Chen, Jiaye Zhang, Yue Xiong, Fang Yuan, Zhen Yang, Tingting Chen, Xinwen Chen, Ping Peng, Qiang Tai, Jian Wang, Fuchun Zhang, Yinxiong Li
medRxiv 2020.05.05.20077610; doi: https://doi.org/10.1101/2020.05.05.20077610
Celebrex adjuvant therapy on COVID-19: An experimental study
Wenxin Hong, Yan Chen, Kai You, Shenglin Tan, Feima Wu, Jiawang Tao, Xudan Chen, Jiaye Zhang, Yue Xiong, Fang Yuan, Zhen Yang, Tingting Chen, Xinwen Chen, Ping Peng, Qiang Tai, Jian Wang, Fuchun Zhang, Yinxiong Li
medRxiv 2020.05.05.20077610; doi: https://doi.org/10.1101/2020.05.05.20077610
Subject Area
Subject Areas
- Addiction Medicine (368)
- Allergy and Immunology (689)
- Anesthesia (184)
- Cardiovascular Medicine (2745)
- Dermatology (235)
- Emergency Medicine (414)
- Epidemiology (12394)
- Forensic Medicine (10)
- Gastroenterology (784)
- Genetic and Genomic Medicine (4257)
- Geriatric Medicine (396)
- Health Economics (699)
- Health Informatics (2756)
- Health Policy (1018)
- Hematology (369)
- HIV/AIDS (879)
- Medical Education (404)
- Medical Ethics (111)
- Nephrology (453)
- Neurology (4034)
- Nursing (216)
- Nutrition (598)
- Oncology (2126)
- Ophthalmology (604)
- Orthopedics (251)
- Otolaryngology (312)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (478)
- Pediatrics (1148)
- Primary Care Research (467)
- Public and Global Health (6650)
- Radiology and Imaging (1446)
- Respiratory Medicine (886)
- Rheumatology (421)
- Sports Medicine (352)
- Surgery (464)
- Toxicology (57)
- Transplantation (192)
- Urology (171)